Table 1.
Variable | Sertraline plus deanxit | Sertraline plus placebo | p value |
---|---|---|---|
(N = 38) | (N = 37) | ||
Age(yr) | |||
Mean ± SD | 62.8 ± 13.1 | 61.5 ± 13.3 | NS |
Gender(%) | |||
Male | 13(34.2%) | 15(40.5%) | NS |
Female | 25(65.8%) | 22(59.5%) | NS |
BMI(body mass index) | |||
Mean ± SD | 28.3 ± 4.1 | 28.0 ± 4.3 | NS |
Employment status | |||
Employed | 14(36.8%) | 12(32.4%) | NS |
Unemployed | 24(63.2%) | 25(67.6%) | NS |
Categories of chronic diseases | |||
Single hypertension | 7 | 7 | NS |
Single diabetes | 8 | 8 | NS |
Single chronic headache | 6 | 5(droup out = 1) | NS |
Single Parkinson’s disease | 5(droup out = 1) | 6 | NS |
chronic obstructive pulmonary diseases | 5 | 5 | NS |
co-morbidity two or more chronic somatic disease | 8 | 7(droup out = 1) | NS |
Baseline score of HAMD | |||
Mean ± SD | 31.6 ± 4.9 | 33.3 ± 5.1 | NS |
Baseline score of HAMA | |||
Mean ± SD | 22.39 ± 4.3 | 23.0 ± 4.5 | NS |
Notes: NS = No Significant.